“The Drugs Don’t Work”: How the Medical-Industrial Complex Systematically Suppresses Negative Studies.
We’ve written a lot about the scientism of mainstream economics, both
here and in ECONNED, and how these trappings have let the discipline
continue to have a special seat at the policy table despite ample
evidence of its failure. As bad as this is, it pales in comparison to
the overt corruption of science at work in the drug arena. Although this
issue comes to light from time to time, often in the context of
litigation, the lay public is largely ignorant of how systematic and
pervasive the efforts are to undermine good research practice in order
to foist more, expensive, and sometimes dangerous drugs onto patients.
Ben Goldacre,
a British doctor and science writer, provides a short overview of one
of the worst scams practiced by Big Pharma: that of suppressing negative
research, in a new piece at the Guardian (hat tip John l). This is the overview:
Drugs are tested by the people who manufacture them, in poorly designed trials, on hopelessly small numbers of weird, unrepresentative patients, and analysed using techniques that are flawed by design, in such a way that they exaggerate the benefits of treatments. Unsurprisingly, these trials tend to produce results that favour the manufacturer. When trials throw up results that companies don’t like, they are perfectly entitled to hide them from doctors and patients, so we only ever see a distorted picture of any drug’s true effects. Regulators see most of the trial data, but only from early on in a drug’s life, and even then they don’t give this data to doctors or patients, or even to other parts of government. This distorted evidence is then communicated and applied in a distorted fashion.
No comments:
Post a Comment
Please, be reasonably respectful when making comments. I do not tolerate in particular sexism, racism nor homophobia. The author reserves the right to delete any abusive comment.
Comment moderation before publishing is... ON